A subgroup of patients with osteosarcoma – a form of bone cancer – could be helped by an existing drug, suggest scientists. In the largest genetic sequencing study of osteosarcoma to date, scientists discovered that 10 percent of patients with a genetic mutation in particular growth factor signalling genes may benefit from existing drugs, known as IGF1R inhibitors.
from Top Health News – ScienceDaily http://ift.tt/2sZcqOY
from Tumblr http://ift.tt/2sZdbr7
No comments:
Post a Comment